对于认知健康,长寿和健康的衰老:我们现在在哪里?
Linda S May-Zhang1, Irwin K Cheah2, Ian T Zajac3
1Blue California, Rancho Santa Margarita, California, USA.
The Proceedings of the Nutrition Society
|September 19, 2025
概括
作为一种饮食化合物,ergothioneine显示出对大脑健康和健康衰老的前景. 补充剂可以改善认知能力并降低与衰老相关的风险,没有发现安全问题.
科学领域:
- 营养神经科学 营养神经科学
- 老年学是指老年学的学科.
- 生物化学 生物化学
背景情况:
- 认知能力下降是全球人口老龄化日益关注的一个问题.
- 饮食中的氨基氨基氨基氨基氨基氨基,被认为具有潜在的神经保护和长寿促进作用.
- 吸收通过OCTN1载体发生.
研究的目的:
- 审查目前关于欧戈氨酸在认知健康和衰老中的作用的证据.
- 综合观察性,干预性和机械学研究的发现.
- 探索欧戈氨酸在促进健康衰老和全身健康方面的潜力.
主要方法:
- 对观察性研究的综述,该研究将血液中恩戈西欧内因水平与健康结果联系起来.
- 对老年人恩戈氨酸补充剂的干预试验的分析.
- 检查了阐明ergothioneine生物通路的机械学研究.
主要成果:
- 低水平的欧戈氨酸与认知障碍,神经退行症和死亡率相关.
- 在老年人中补充剂可以增强认知,记忆和睡眠,并稳定生物标志物.
- 欧戈氨酸减轻氧化应激,神经炎症,并保持线粒体功能.
结论:
- 欧戈氨酸是一种有前途的营养干预,用于认知性和健康的衰老.
- 它支持与衰老相关的多个生理系统,包括心血管和代谢健康.
- 需要进一步进行大规模的长期试验,以确认因果关系并优化欧戈氨酸的使用.
相关概念视频
Aging
612
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
612
The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


